Please assess the completion status of the following clinical trial:

Trial Title: Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adults aged 18 years and older~* Individuals who have received a diagnosis for type 2 diabetes mellitus~* Enrolled as a patient at a participating community health center~* Individuals currently being treated with oral and/or injectable diabetes medications~Exclusion Criteria:~* Non-English speakers~* Individuals who report they do not have a cell phone~* Individuals unwilling and/or not able to provide written informed consent~* Individuals with unintelligible speech (e.g., dysarthria)~* Individuals with a severe hearing or visual impairment~* Individuals who report a caregiver administers their diabetes medications Individuals who fail the cognitive screener administered during the baseline survey~* Individuals who cannot receive, read, and respond to a text after instruction from a trained research assistant~* Individuals whose most recent (within 12 months) HbA1c value was 6.8% or greater

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- REACH (Type: EXPERIMENTAL): Participants will receive REACH text messages (individual-focused text messaging tailored to user's individual barriers to adherence and targeted to address other self-care behaviors) for 12 months.~All participants will also receive text messages advising how to access their study A1c test results, receive quarterly newsletters on healthy living with diabetes, and have access to a Helpline for study- and diabetes medication-related questions.
- REACH + FAMS (Type: EXPERIMENTAL): In addition to the REACH text messages tailored to user's individual barriers to adherence, participants will receive FAMS components (monthly phone coaching and text messages supporting a goal set in coaching, plus the option to invite a family member/support person to receive text messages) for six months. After six months, participants in this arm will receive REACH text messages only.~All participants will also receive text messages advising how to access their study A1c test results, receive quarterly newsletters on healthy living with diabetes, and have access to a Helpline for study- and diabetes medication-related questions.
- Helpline and A1c results (Type: ACTIVE_COMPARATOR): Participants assigned to the control group will complete measures at each time point and maintain care as usual (i.e., medical treatment and physician monitoring).~All participants will receive text messages advising how to access their study A1c test results, receive quarterly newsletters on healthy living with diabetes, and have access to a Helpline for study- and diabetes medication-related questions.

Based on this trial design, predict the completion outcome and termination type (if applicable).